Involvement of p38 MAP kinase in apoptotic and proliferative alteration in human colorectal cancers

Anticancer Research

Volumn 19, Issue 6 B, 1999, Pages 5283-5291

  Miki, Hiroyuki ^a   Yamada, Hirotaka ^a   Mitamura, Keiji ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Calmodulin dependent protein kinase; Colorectal neoplasm; ERK; Mitogen activated protein kinase; p38; Proliferation

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ADENOCARCINOMA; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL;

ADENOCARCINOMA; APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CELL NUCLEUS; COLORECTAL NEOPLASMS; ENZYME ACTIVATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 0033382513     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Raingeaud J, Gupta S, Rogers J, Dickens M, Han J, Ulevitch RJ, Davis RJ: Pro-inflamatory cytokines and environmental stress cause p38 MAP kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270: 7420-7426, 1995.
2. Cobb MH, Goldsmith EJ: How MAP kinases are regulated. J Biol Chem 270: 14843-14846, 1995.
3. Zhang F, Strand A, Robbins D, Cobb MH, Goldsmith EJ: Atomic structrue of the MAP kinase ERK 2 at 2.3Å resolution. Nature 367: 704-710, 1994.
4. Dérijard B, Hibi M, Wu I-H, Barrett T, Su B, Deng T, Karin M, Davis RJ: JNK1: a protein kinase stimulated by uv light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037, 1994.
5. Pages G, Lenormand P, L'Allemain G, Chambard JC, Meloche S, Pouyssegur J: Mitogen- activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA 90: 8319-8323, 1993.
6. Mii S, Khalil RA, Morgan KG, Ware JA, Kent KC: Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells. Am J Physiol 270: H142-H150, 1996.
7. Pencil SD, Ton Y, Nicolson GL: Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma. Breast Cancer Res Treat 25: 165-174, 1993.
8. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Stickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, Young PR: A protein kinase involved in the regulation of inflamatory cytokine biosynthesis. Nature 372: 739-746, 1994.
9. Wang X, Ron D: Stress-induced phosphorylation and activation of the transcription factor CHOP(GADD153) by p38 MAP kinase. Science 272: 1347-1349, 1996.
10. Zervos AS, Faccio L, Gatto JP, Kyriakis JM, Brent R: Mxi 2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein. Proc Natl Acad Sci USA 92: 10531-10534, 1995.
11. Crawley JB, Rawlinson L, Lali FV, Page TH, Saklatvala J, Foxwell BMJ: T cell proliferation in response to interleukins 2 and 7 requires p38 MAP kinase activation. J Biol Chem 272: 15023-15027, 1997.
12. Parry RV, Boulougouris G, Sansom DM, Ward SG: Phorbol esters modulate the coupling of the T cell costimulatory molecule CD28 to phosphatidylinositol 3-kinase. Biochem Soc Trans 25: 305S, 1997.
13. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
14. Green DR, Scott DW: Activation-induced apoptosis in lymphocytes. Curr Opin Immunol 6: 476-487, 1994.
15. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg, ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995.
16. Ichijo H, Nishida E, Irie K, ten Dyke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y: Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94, 1997.
17. Watabe M, Kawazoe N, Masuda Y, Nakajo S, Nakaya K: Bcl-2 protein inhibits Bufalin-induced apoptosis through inhibition of mitogen-activated protein kinase activation in human leukemia U937 cells. Cancer Res 57: 3097-3100, 1997.
18. Kummer JL, Rao PK, Heidenreich KA: Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J Biol Chem 272: 20490-20494, 1997.
19. Renzo MFD, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L, Nordlinger B, Bretti S, Bottardi S, Giordano S, Plebani M, Gespach C, Comoglio PM: Overexpression and amplification of Met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1: 147-154, 1995.
20. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Res 11: 1475-1489, 1983.
21. Young PR, McLaughlin MM, Kumar S, Kassis S, Doyle ML, McNulty D, Gallagher TF, Fisher S, McDonnell PC, Carr SA, Huddleston MJ, Seibel G, Porter TG, Livi GP, Adams JL, Lee JC: Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J Biol Chem 272: 12116-12121, 1997.
22. Oka H, Chatani Y, Hoshino R, Ogawa O, Kahehi Y, Terachi T, Okada Y, Kawaichi M, Kohno M, Yoshida O: Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res 55: 4182-4187, 1995.
23. Chen RH, Sarnecki C, Blenis J: Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol Cell Biol 12: 915-927, 1992.
24. Takishima K, Griswold-Prenner I, Ingebritsen T, Rosner MR: Epidermal growth factor (EGF) receptor T669 peptide kinase from 3T3-L1 cells is an EGF-stimulated "MAP" kinase. Proc Natl Acad Sci USA 88: 2520-2524, 1991.
25. Lothe RA, Peltomaki P, Meling GI, Aaltonen LA, Nystrom-Lahti M, Pylkkanen L, Heimdal K, Andersen TI, Moller P, Rognum TO, Fossa SD, Haldorsen T, Langmark F, Brogger A, de la Chapelle A, Borresen A-L: Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 53: 5849-5842, 1993.
26. Kihana T, Tsuda H, Teshima S, Nomoto K, Tsugane S, Sonoda T, Matsuura S, Hirohashi S: Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix. Cancer 73: 148-153, 1994.
27. Ohwada S, Ogawa T, Izumi M, Inoue T, Teshigawara O, Ikeyama T, Kusaba T, Roppongi T, Iino Y, Morishita Y: Effects of 5′-DFUR and OK-432 on cytokines and thymidine phosphorylase in tumor tissue of gastric cancer patients. Anticancer Res 17: 2313-2318, 1997.
28. Attar BM, Atten MJ, Holian O: MAPK activity is down-regulated in human colon adenocarcinoma: correlation with PKC activity. Anticancer Res 16: 395-400, 1996.
29. Atten MJ, Attar BM, Holian O: Decreased MAP kinase activity in human gastric adenocarcinoma. Biochem Biophysic Res Com 212: 1001-1006, 1995.
30. Shpitz B, Bomstein Y, Mekori Y, Cohen R, Kaufman Z, Grankin M, Bernheim J: Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon. Am J Surg 174: 425-430, 1997.
31. Lee CS: Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in situ and invasive carcinomas of the extrahepatic biliary tract. Cancer 78: 1881-1887, 1996.
32. Kim R, Clarke MR, Melhem MF, Young MA, Vanbibber MM, Safatle-Ribeiro AV, Ribeiro U Jr, Reynolds JC: Expression of p53, PCNA, and C-erbB-2 in Barrett's metaplasia and adenocarcinoma. Dig Dis Sci 42: 2453-2462, 1997.
33. Rhoads JM, Argenzio RA, Chen W, Rippe RA, Westwick JK, Cox AD, Berschneider HM, Brenner DA: L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases. Am J Physiol 272: G943-953, 1997.
34. Kurino M, Fukunaga K, Ushio Y, Miyamoto E: Cyclic AMP inhibits activation mitogen-activated protein kinase and cell proliferation in response to growth factors in cultured rat cortical astrocytes. J Neurochem 67: 2246-2255, 1996.
35. Steller H: Mechanisms and genes of cellular suicide. Science 267: 1445-1449, 1995.
36. Fridell YW, Jin Y, Quilliam LA, Burchert A, McCloskey P, Spizz G, Varnum B, Der C, Liu ET: Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase. Mol Cell Biol 16: 135-145, 1996.
37. Strasser A: Life and death during lymphocyte development and function: evidence for two distinct killing mechanisms. Curr Opin Immunol 7: 228-234, 1995.
38. Juo P, Kuo CJ, Reynolds SE, Konz RF, Raingeaud J, Davis RJ, Biemann H-P, Blenis J: Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol Cell Biol 17: 24-35, 1997.
39. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC: SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364: 229-233, 1995.
40. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ: Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med 184: 429-440, 1996.